Grace Therapeutics, Inc.
GRCE · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10 | -$13 | -$42 | -$10 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | -$3 | -$2 | -$10 | -$1 |
| Stock-Based Comp. | $1 | $1 | $2 | $1 |
| Change in WC | $0 | -$1 | $0 | -$3 |
| Other Non-Cash | -$3 | $3 | $34 | -$5 |
| Operating Cash Flow | -$15 | -$12 | -$16 | -$17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$0 | -$7 | -$5 | -$35 |
| Inv. Sales/Matur. | $0 | $7 | $18 | $31 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $13 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $15 | $8 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$0 | $0 | $0 |
| Financing Cash Flow | $14 | $7 | $0 | $0 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$1 | -$5 | -$2 | -$21 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23 | $28 | $30 | $51 |
| End Cash | $22 | $23 | $28 | $30 |
| Free Cash Flow | -$15 | -$12 | -$16 | -$17 |